Cargando…
The role of dyslipidemia and statins in venous thromboembolism
Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59643/ https://www.ncbi.nlm.nih.gov/pubmed/11806791 http://dx.doi.org/10.1186/cvm-2-4-165 |
| _version_ | 1782120092435218432 |
|---|---|
| author | Ray, Joel G Rosendaal, Frits R |
| author_facet | Ray, Joel G Rosendaal, Frits R |
| author_sort | Ray, Joel G |
| collection | PubMed |
| description | Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the prevention and treatment of VTE and suggest future directions for research. |
| format | Text |
| id | pubmed-59643 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2001 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-596432001-11-06 The role of dyslipidemia and statins in venous thromboembolism Ray, Joel G Rosendaal, Frits R Curr Control Trials Cardiovasc Med Review Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the prevention and treatment of VTE and suggest future directions for research. BioMed Central 2001 2001-07-20 /pmc/articles/PMC59643/ /pubmed/11806791 http://dx.doi.org/10.1186/cvm-2-4-165 Text en Copyright © 2001 BioMed Central Ltd |
| spellingShingle | Review Ray, Joel G Rosendaal, Frits R The role of dyslipidemia and statins in venous thromboembolism |
| title | The role of dyslipidemia and statins in venous thromboembolism |
| title_full | The role of dyslipidemia and statins in venous thromboembolism |
| title_fullStr | The role of dyslipidemia and statins in venous thromboembolism |
| title_full_unstemmed | The role of dyslipidemia and statins in venous thromboembolism |
| title_short | The role of dyslipidemia and statins in venous thromboembolism |
| title_sort | role of dyslipidemia and statins in venous thromboembolism |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59643/ https://www.ncbi.nlm.nih.gov/pubmed/11806791 http://dx.doi.org/10.1186/cvm-2-4-165 |
| work_keys_str_mv | AT rayjoelg theroleofdyslipidemiaandstatinsinvenousthromboembolism AT rosendaalfritsr theroleofdyslipidemiaandstatinsinvenousthromboembolism AT rayjoelg roleofdyslipidemiaandstatinsinvenousthromboembolism AT rosendaalfritsr roleofdyslipidemiaandstatinsinvenousthromboembolism |